| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3c16b0bbc3bd05d9455b6bb499f1845 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-037 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate |
2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07d7c79d1864be861214e9d5ca379c04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdc6b371ed0b2d771fd80220613b893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1144ddb9a2bb4e0fdd1cb71fe220c39f |
| publicationDate |
2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016296538-A1 |
| titleOfInvention |
Predictive and response biomarker for th-302 anti-cancer therapy |
| abstract |
Cancer patients likely to respond to HAP treatment exhibit tumor tissues with high levels of hypoxia, which can be measured using PET imaging with [18F]-HX4. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071109-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504075-B2 |
| priorityDate |
2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |